Max Healthcare Institute has announced its financial results for the quarter ending March 31, 2026, showcasing a notable increase in total income and net profit. The healthcare provider continues to demonstrate strong financial performance.
In the March 2026 quarter, Max Healthcare Institute reported a total income of ₹2,190.72 crore, marking a 12% year-on-year (YoY) increase from ₹1,956.66 crore in the same period last year.
Sequentially, this represents a 3.7% rise from ₹2,112.90 crore in the December 2025 quarter.
Net profit for the quarter rose by 7.3% YoY to ₹342.22 crore, up from ₹319.00 crore a year ago.
Compared to the previous quarter, net profit increased by 13.7% from ₹300.92 crore.
For the financial year 2025-26, Max Healthcare Institute's total income grew by 18.8% YoY to ₹8,536.07 crore, compared to ₹7,184.10 crore in the previous year.
The net profit for FY26 saw a significant rise of 34.1% YoY, reaching ₹1,442.41 crore from ₹1,075.88 crore.
Read More: Page Industries Share Price Gains Over 2% on Q4 FY26 Earnings Results: Net Profit up 9% YoY!
The company has recommended a final dividend of ₹2 per equity share, equivalent to 20% of the face value of ₹10 each.
This dividend is subject to approval by the Members of the Company and is expected to be paid within 30 days following the conclusion of the forthcoming Annual General Meeting.
As of May 21, 2026, at 3:30 PM, Max Healthcare Institute share price on NSE was closed at ₹1,091.10 up by 1.43% from the previous closing price.
Max Healthcare Institute's financial results for Q4 2026 and FY26 reflect a strong performance with significant growth in both income and net profit. The recommended dividend further underscores the company's robust financial health.
Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: May 22, 2026, 7:56 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
